Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 18th:
Lennar Corporation (LEN - Free Report) : This homebuilder in the United States, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.
Lennar has a PEG ratio of 0.95, compared with 1.06 for the industry. The company possesses a Growth Score of B.
JELD-WEN Holding, Inc. (JELD - Free Report) : This designer and manufacturer of doors and windows, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 86.1% over the last 60 days.
JELD-WEN has a PEG ratio 0.86, compared with 1.21 for the industry. The company possesses a Growth Score of B.
Target Corporation (TGT - Free Report) : This general merchandise retailer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.
Target has a PEG ratio 2.86, compared with 5.20 for the industry. The company possesses a Growth Score of A.
West Pharmaceutical Services, Inc. (WST - Free Report) : This manufacturer and seller of containment and delivery systems for injectable drugs and healthcare products, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
West Pharmaceutical has a PEG ratio 3.71, compared with 5.30 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 18th:
Lennar Corporation (LEN - Free Report) : This homebuilder in the United States, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.
Lennar has a PEG ratio of 0.95, compared with 1.06 for the industry. The company possesses a Growth Score of B.
JELD-WEN Holding, Inc. (JELD - Free Report) : This designer and manufacturer of doors and windows, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 86.1% over the last 60 days.
JELD-WEN has a PEG ratio 0.86, compared with 1.21 for the industry. The company possesses a Growth Score of B.
Target Corporation (TGT - Free Report) : This general merchandise retailer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.
Target has a PEG ratio 2.86, compared with 5.20 for the industry. The company possesses a Growth Score of A.
West Pharmaceutical Services, Inc. (WST - Free Report) : This manufacturer and seller of containment and delivery systems for injectable drugs and healthcare products, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
West Pharmaceutical has a PEG ratio 3.71, compared with 5.30 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on TGT - FREE
Get the latest research report on LEN - FREE
Get the latest research report on WST - FREE
Get the latest research report on JELD - FREE